Stem cell therapy for diabetes essay

The strategy would also benefit those with type 2 diabetes to a lesser extent by replacing failing b-cells, although the insulin resistance in peripheral tissues would remain present.

Methods and Findings We pooled participant-level data from twenty-two eligible clinical trials that satisfied our inclusion criteria, with a total of patients. Research for both adult stem cell and blastocyst stem cell technologies are the only practical option in approaching a cure or more effective treatment for ALS.

The blastodermic vessicle comprises three chief constructions: Alternately, methods could be developed to coax stem cells grown in the laboratory to differentiate into insulin-producing b-cells.

There are three different ways to harvest the necessary stem cells for neuron replacement: Insulin facilitates uptake of glucose, the main fuel source, into cells of tissues such as muscle. Undifferentiated root cells are located with other mature differentiated cells in the pancreatic canal.

Efficient differentiation of human embryonic stem cells to definitive endoderm. Abstract Background Stem cell therapy is a promising therapeutic modality for advanced diabetes mellitus DM. However, many challenges must be addressed before a particular cell type will become established for this approach.

Further research in mice has shown that a individual root cell transplant can renew cell blood line of descents and distinguish into multiple cell types. Conclusions Stem cell transplantation can represent a safe and effective treatment for selected patients with DM.

A single 68 kg lb patient requires transplantation of roughly — million islet cells to effectively resolve the disease [ 3 — 5 ].

Both of these technologies require stem cells, but are challenging to safely retrieve and utilize through the current treatment methods, which is why it is essential to continue to support and fund this research.

Other Potential Sources of Stem Cells Derived from Adult Cells Furthermore, various reports have also described putative stem cells in the liver, spleen, central nervous system, and bone marrow that can differentiate into insulin-producing cells. In the last decade, reports have described various putative pancreatic stem cells embedded in the pancreatic islets, 2425 pancreatic ducts, 2326 among the exocrine acinar cells, 2021 and in unspecified pancreatic locales 1927 in rodent models, as well as from human adult pancreatic cell lines, 28 islet tissue, 29 and non-islet tissues discarded after islets have been removed for transplantation.

According to the National Diabetes Fact Sheet, which was compiled using information from the Centers for. Insulin-secreting cells from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice.

Although projections for increases in diabetes prevalence suggest that the greatest percentage gains will occur in Asia and South America, 23 all nations will experience a rising disease burden.

Studies in which the subjects had any additional pathologies or altered endocrine status other than DM were excluded. Brain root cells have found to be able to distinguish into a broad assortment of cell types and can renew the haematopoietic system NIH Stem Cell, In healthy individuals, b-cells counteract sharp increases in blood glucose, such as those caused by a meal, by releasing an initial "spike" of insulin within a few minutes of the glucose challenge.

ALS is a progressive neurodegenerative disease which attacks the neurons in the brain and spinal cord that control voluntary movement, eventually leading to respiratory failure and death Kamel et al.

Growing such high numbers of stem cells in this fashion can prove problematic though, while the cells reproduce indefinitely they become more susceptible to mutation and may cause tumors following transplant Ormerod et. Essentials of Physical Anthropology: Thus, the reserve of the stem cells, practically lost for the latest 15 — 20 years, is restored.

Kieffer and colleagues note, however, that such treatments can cause gastrointestinal problems, weight gain and low blood glucose levels, and some patients may not even respond to them.

Are Stem Cells the Next Frontier for diabetes treatment?

Global and societal implications of the diabetes epidemic. Cell replacement therapy is currently the only stem cell treatment of neurodegenerative diseases such as ALS, but researchers are trying to find new ways of treating and possibly curing ALS.

In order to manage blood glucose levels, patients with type 2 diabetes are often treated with oral medication - such as metformin - insulin injections, or a combination of both. New modern technology Diabetes Type 2 Stem Cell Treatment Diabetes type 2 is a metabolic disorder that is characterized by high blood sugar and lack of insulin, a hormone produced in the pancreas that regulates the metabolism of carbohydrates.

Numerous in vivo animal studies demonstrated the potential advantages of using stem cells to treat DM. All relevant data are within the paper and its Supporting Information files. The goal of treatment of ALS is to slow and eventually stop cell loss progressing to the point of functional impairment.

Given current debate on this issue, the routine clinical application of stem-cell based regenerative therapy for the treatment of diabetes remains a future goal, albeit one with great potential. As researchers learn more about the mechanisms that govern stem cell programming, differentiation, and renewal, their ability to identify, isolate, and culture candidate stem cells will continue to improve.

We aim to critically evaluate and synthesize clinical evidence on the safety and efficiency of different types of stem cell therapy for both T1DM and T2DM.

Based on several recent discoveries, however, researchers have begun to ask if a new treatment approach is on the horizon — can stem cells that are derived from adult or embryonic tissues generate new pancreatic b-cells to replace those that have failed or been destroyed.

Even if the regenerative properties of the pancreas remain functional, the continued presence of these T-cells effectively counteracts any endogenous repair and would likely decimate populations of newly-regenerated or transplanted insulin-producing cells.

Several recent studies in rodents have indicated that the adult pancreas contains some type of endocrine progenitor cells that can differentiate toward b-cells.

It is typically a chronic disease with a ten-year shortened life expectancy and symptoms such as: However, it should be noted that directed differentiation of ES cells toward the b-cell has not been reported.

The blastodermic vessicle comprises three chief constructions: the blastocele ; a fluid filled pit, the trophectoderm ; bed of environing cells and the inner cell mass ; which is a aggregation of around 30 cells situated at one terminal of the blastodermic vessicle (NIH Stem Cell, ).

Stem Cell Therapy for Diabetes It has been suggested that stem cell therapy is the answer to treating many patients greatly improving their quality of life. [tags: Multicellular Organisms, Stem Cell Therapy] In this essay, I will explain embryonic stem cells concept, and importance of utilizing it in medical development.

Stem Cell Therapy Essay

Moreover, I. Type 1 diabetes is an appropriate candidate disease for stem cell therapy, as the causative damage is localized to a particular cell type.

Diabetes Type 2 - Stem cells treatment clinic

In theory, stem cells that can differentiate into b-cells in response to molecular signals in the local pancreatic environment could be introduced into the body, where they would migrate to the. Stem Cell Therapy for Diabetes Essay Words | 5 Pages. Diabetes, or fully named Diabetes Mellitus is when a person has high blood sugar and that is cause by the lack of insulin produced by the pancreas or it is when the cells do not respond to the insulin produced, it is also according to the type of diabetes that the cause may be different.

Apr 13,  · Stem cell therapy is a promising therapeutic modality for advanced diabetes mellitus (DM). This study presents a meta-analysis of relevant clinical trials. A new stem cell-based treatment for type 2 diabetes has proved effective in mice, improving glucose metabolism, insulin sensitivity and leading to rapid weight loss.

Stem cell therapy for diabetes essay
Rated 0/5 based on 25 review
Stem cell-based therapy for type 2 diabetes shows promise